Volunteers with Down’s syndrome could help find Alzheimer’s drugs
Those with the syndrome have more of a protein implicated in dementia
Dementia looks likely to dominate old age in the 21st century. A study in this week’s Nature Medicine reckons the number of Americans developing it each year will rise from 500,000 in 2020 to 1m in 2060. And though drugs that have some effect on Alzheimer’s disease, dementia’s most common manifestation, have recently been assessed in America and Britain, not everyone is convinced.
Explore more
This article appeared in the Science & technology section of the print edition under the headline “Fortune’s wheel”
From the January 18th 2025 edition
Discover stories from this section and more in the list of contents
Explore the editionMore from Science & technology
Can you breathe stress away?
It won’t hurt to try. But scientists are only beginning to understand the links between the breath and the mind
The Economist’s science and technology internship
We invite applications for the 2025 Richard Casement internship
A better understanding of Huntington’s disease brings hope
Previous research seems to have misinterpreted what is going on
Is obesity a disease?
It wasn’t. But it is now
Should you start lifting weights?
You’ll stay healthier for longer if you’re strong
Does melatonin work for jet lag?
It can help. But it depends where you’re going